Swanson Donald William
Transaction: 07/19/2025
OTHER
Change
0
Price
Not reported
Filing
08/22/2025
Type
OTHER
Healthy Extracts Inc.
HYEX • Drug Manufacturers - Specialty & Generic
$1.24
▲ +0.00 (+0.03%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$20.27M
Growth
—
Cash Flow
2/5
Trend
Volatile
Evidence
Positive free cash flow · 0.02Manageable debt level · 0.11Weak liquidity · 0.79Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 19, 2026, 12:17 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.24
Change0.03%
Shares Out16.34M
Market Cap$20.27M
Enterprise Value$29.15M
52W Range0.81 - 3.35
Beta-0.77
P/E-23.05
P/S3.22
P/B0.90
P/FCF40.51
EV/Sales4.63
Price$1.24
Change0.03%
Shares Out16.34M
Market Cap$20.27M
Enterprise Value$29.15M
52W Range0.81 - 3.35
Beta-0.77
P/E-23.05
P/S3.22
P/B0.90
P/FCF40.51
EV/Sales4.63
EV/EBITDA-34.93
EV/FCF58.26
Earnings Yield-4.34%
FCF Yield2.47%
Dividend Yield0.00%
Gross Margin53.69%
Oper. Margin-20.92%
Profit Margin-19.53%
Debt/Eq0.11
Current Ratio0.79
Quick Ratio0.29
Volume100.00
Avg Volume476.00
EPS Surprise-0.12
Investment DNA
How strong this company looks for long-term investors
36
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
39/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
64/100
Why this score▼
Positive free cash flow · 0.02Manageable debt level · 0.11Weak liquidity · 0.79Negative growth trendWeak profitability
Analyst view
No analyst data available now.
Financial Health
Score8 / 20
Debt / Equity: 0.11
Current Ratio: 0.79
Quick Ratio: 0.29
Status: Moderate
Warnings
- Weak Liquidity
- Weak quick ratio
Insider Transactions
Recent executive and insider activity
⚠ 3 high-volume insider sells detected
Croyle William Russell Jr
Transaction: 06/30/2023
BUY
Change
+500,000
Price
$5.00
Filing
07/17/2023
Type
BUY
Croyle William Russell Jr
Transaction: 12/31/2021
BUY
Change
+200,000
Price
$0.05
Filing
08/16/2022
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Swanson Donald William | OTHER | 0 | Not reported | 07/19/2025 | 08/22/2025 |
| Croyle William Russell Jr | BUY | +500,000 | $5.00 | 06/30/2023 | 07/17/2023 |
| Croyle William Russell Jr | BUY | +200,000 | $0.05 | 12/31/2021 | 08/16/2022 |
| Croyle William Russell Jr | SELL | 0 | Not reported | 09/24/2019 | 08/16/2022 |
| Pitts Kevin | BUY | +610,112 | Not reported | 04/13/2020 | 07/08/2022 |
| Pitts Kevin | BUY | +2,000,000 | $0.05 | 12/20/2019 | 07/08/2022 |
| Pitts Kevin | BUY | +1,620,000 | Not reported | 02/13/2019 | 07/08/2022 |
| Madden Robert Michael | SELL | 0 | $0.05 | 05/31/2022 | 07/05/2022 |
| Javia Sanjeevkumar Ratanshi | OTHER | 0 | Not reported | 02/04/2019 | 02/22/2019 |
| Pitts Kevin | BUY | +250,000 | Not reported | 11/20/2018 | 12/06/2018 |
| Pitts Kevin | SELL | 0 | Not reported | 09/28/2018 | 10/22/2018 |
| Pitts Kevin | BUY | +348,601 | Not reported | 09/28/2018 | 10/22/2018 |
| Pitts Kevin | OPTION | +20,402 | Not reported | 10/17/2017 | 10/22/2018 |
| Stiles Patrick | SELL | -51,457,126 | Not reported | 10/17/2017 | 10/24/2017 |
| COVELY FRED | BUY | 0 | Not reported | 10/17/2017 | 10/23/2017 |
| COVELY FRED | BUY | +41,403 | Not reported | 10/17/2017 | 10/23/2017 |
| COVELY FRED | BUY | +1,200,000 | $0.25 | 10/17/2017 | 10/23/2017 |
| BOSSUNG WILLIAM C | BUY | +146,330 | Not reported | 10/17/2017 | 10/23/2017 |
| Nejman Joseph | SELL | -33,466,044 | Not reported | 05/19/2017 | 05/25/2017 |
| Nejman Joseph | SELL | -6,024,536 | Not reported | 05/19/2017 | 05/25/2017 |